US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 6.500
  • -0.010-0.15%
Close Apr 26 16:00 ET
  • 6.500
  • 0.0000.00%
Post 16:20 ET
115.50MMarket Cap-4545P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
-3.08M
Net income from continuing operations
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Change In working capital
-58.08%1.6M
-42.48%1.55M
68.23%1.5M
30.81%675K
-637.02%-2.13M
155.62%3.82M
167.39%2.7M
743.40%894K
44.94%516K
-1,356.52%-289K
-Change in payables and accrued expense
-107.72%-169K
86.57%-9K
-6.05%1.37M
6.15%276K
-432.47%-1.8M
38.11%2.19M
-106.09%-67K
1,271.70%1.45M
-26.97%260K
2,256.52%542K
-Change in other current assets
209.97%353K
-82.31%144K
124.64%138K
55.86%399K
60.53%-328K
-252.75%-321K
994.51%814K
---560K
--256K
---831K
-Change in other working capital
-27.37%1.42M
----
----
----
----
--1.95M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
---3.08M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
-131K
260.41%14.49M
-105.15%-578K
14.03M
Net common stock issuance
-83.41%5.29M
--901K
-92.91%1.13M
--3.26M
--0
--31.88M
--0
--15.88M
--0
--16M
Proceeds from stock option exercised by employees
--11.19M
--0
--14K
--10.48M
--702K
--0
--0
--0
--0
--0
Net other financing activities
65.74%-1.39M
112.21%16K
68.49%-437K
9.52%-523K
77.19%-450K
---4.07M
---131K
---1.39M
---578K
---1.97M
Cash from discontinued financing activities
Financing cash flow
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
---131K
260.41%14.49M
-105.15%-578K
--14.03M
Net cash flow
Beginning cash position
248.19%19.99M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
--5.74M
247.19%23.64M
88.13%13.57M
--16.69M
--5.74M
Current changes in cash
-106.08%-867K
19.58%-2.93M
-125.24%-2.54M
392.60%9.13M
-141.32%-4.53M
148.19%14.25M
-241.80%-3.65M
2,585.93%10.07M
---3.12M
--10.95M
End cash Position
-4.34%19.13M
-4.34%19.13M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
248.19%19.99M
247.19%23.64M
88.13%13.57M
--16.69M
Free cash flow
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
---3.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M-3.08M
Net income from continuing operations -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Change In working capital -58.08%1.6M-42.48%1.55M68.23%1.5M30.81%675K-637.02%-2.13M155.62%3.82M167.39%2.7M743.40%894K44.94%516K-1,356.52%-289K
-Change in payables and accrued expense -107.72%-169K86.57%-9K-6.05%1.37M6.15%276K-432.47%-1.8M38.11%2.19M-106.09%-67K1,271.70%1.45M-26.97%260K2,256.52%542K
-Change in other current assets 209.97%353K-82.31%144K124.64%138K55.86%399K60.53%-328K-252.75%-321K994.51%814K---560K--256K---831K
-Change in other working capital -27.37%1.42M------------------1.95M----------------
Cash from discontinued investing activities
Operating cash flow -17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M---3.08M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M-131K260.41%14.49M-105.15%-578K14.03M
Net common stock issuance -83.41%5.29M--901K-92.91%1.13M--3.26M--0--31.88M--0--15.88M--0--16M
Proceeds from stock option exercised by employees --11.19M--0--14K--10.48M--702K--0--0--0--0--0
Net other financing activities 65.74%-1.39M112.21%16K68.49%-437K9.52%-523K77.19%-450K---4.07M---131K---1.39M---578K---1.97M
Cash from discontinued financing activities
Financing cash flow -45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M---131K260.41%14.49M-105.15%-578K--14.03M
Net cash flow
Beginning cash position 248.19%19.99M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M--5.74M247.19%23.64M88.13%13.57M--16.69M--5.74M
Current changes in cash -106.08%-867K19.58%-2.93M-125.24%-2.54M392.60%9.13M-141.32%-4.53M148.19%14.25M-241.80%-3.65M2,585.93%10.07M---3.12M--10.95M
End cash Position -4.34%19.13M-4.34%19.13M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M248.19%19.99M247.19%23.64M88.13%13.57M--16.69M
Free cash flow -17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M---3.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg